Fosinopril and carvedilol reverse hypertrophy and change the levels of protein kinase Cε and components of its signaling complex

Cardiovascular Drugs and Therapy

Volumn 20, Issue 4, 2006, Pages 259-271

  He, Hua ^a   Wang, Wen ^a   Zhang, Huimin ^a   Ma, Liyuan ^a   Wu, Haiying ^a   Wang, Peihe ^a   Gao, Jiuming ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Carvedilol; Fosinopril; Heart failure; Pressure overload hypertrophy; Protein kinase C

Indexed keywords

BINDING PROTEIN; CARVEDILOL; FOSINOPRIL; POTASSIUM CHLORIDE; PROTEIN KINASE C EPSILON; PROTEIN KINASE LYN; PROTEIN MAD1;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART FAILURE; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RAT; WESTERN BLOTTING;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CARBAZOLES; CARDIOMEGALY; FOSINOPRIL; HEART FAILURE, CONGESTIVE; LUNG; MALE; MYOCARDIUM; PROPANOLAMINES; PROTEIN KINASE C-EPSILON; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 33750710740     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-006-0079-5     Document Type: Article

References (38)

1. Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 1993;55:55-75.
2. Chien KR GA, Hunter JJ, Hunter JJ. Molecular biology of cardiac hypertrophy and heart failure. Philadelphia: WB Saunders Co, 1998.
3. Inagaki K, Iwanaga Y, Sarai N, Onozawa Y, Takenaka H, Mochly-Rosen D, et al. Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta. J Mol Cell Cardiol 2002;34:1377-85.
4. Sabri A, Steinberg SF. Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol Cell Biochem 2003;251:97-101.
5. Pass JM, Zheng Y, Wead WB, Zhang J, Li RC, Bolli R, et al. PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. Am J Physiol Heart Circ Physiol 2001;280:H946-55.
6. Goldspink PH, Montgomery DE, Walker LA, Urboniene D, McKinney RD, Geenen DL, et al. Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res 2004;95:424-32.
7. Ping P, Song C, Zhang J, Guo Y, Cao X, Li RC, et al. Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest 2002;109:499-507.
8. Mochly-Rosen D, Wu G, Hahn H, Osinska H, Liron T, Lorenz JN, et al. Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. Circ Res 2000;86:1173-9.
9. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, Walsh RA. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ Res 2000;86:1218-23.
10. Iwata M, Maturana A, Hoshijima M, Tatematsu K, Okajima T, Vandenheede JR, et al. PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists. Biochem Biophys Res Commun 2005;327:1105-13.
11. Arya R, Kedar V, Hwang JR, McDonough H, Li HH, Taylor J, et al. Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J Cell Biol 2004;167:1147-59.
12. Ping P, Zhang J, Pierce WM, Jr., Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res 2001;88:59-62.
13. Reiffel JA. Practical algorithms for pharmacologic management of the post myocardial infarction patient. Clin Cardiol 2005;28:I28-37.
14. Rudolph B, Hueber AO, Evan GI. Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation. Oncogene 2001;20:1164-75.
15. Kametani R, Miura T, Harada N, Shibuya M, Wang R, Tan H, et al. Carvedilol inhibits mitochondrial oxygen consumption and superoxide production during calcium overload in isolated heart mitochondria. Circ J 2006;70:321-6.
16. Horani MH, Haas MJ, Mooradian AD. Suppression of hyperglycemia-induced superoxide formation and endothelin-1 gene expression by carvedilol. Am J Ther 2006;13:2-7.
17. Yeh HI, Lee PY, Su CH, Tian TY, Ko YS, Tsai CH. Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment. Am J Hypertens 2006;19:129-35.
18. Kim L, Lee T, Fu J, Ritchie ME. Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo. Am J Physiol 1999;277:H1808-16.
19. Flesch M, Ettelbruck S, Rosenkranz S, Maack C, Cremers B, Schluter KD, et al. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes. Cardiovasc Res 2001;49:371-80.
20. Vlahos CJ, McDowell SA, Clerk A. Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov 2003;2:99-113.
21. Ping P. Identification of novel signaling complexes by functional proteomics. Circ Res 2003;93:595-603.
22. Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG, Jr., Meyer TE. Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens 1998;16:1813-22.
23. Lorenz JN, Robbins J. Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. Am J Physiol 1997;272:H1137-46.
24. Schunkert H, Weinberg EO, Bruckschlegel G, Riegger AJ, Lorell BH. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J Clin Invest 1995;96:2768-74.
25. Pogwizd SM, Qi M, Yuan W, Samarel AM, Bers DM. Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 1999;85:1009-19.
26. Dohke T, Wada A, Isono T, Fujii M, Yamamoto T, Tsutamoto T, et al. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Card Fail 2006;12:77-84.
27. Heinke MY, Wheeler CH, Yan JX, Amin V, Chang D, Einstein R, et al. Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis 1999;20:2086-93.
28. Weekes J, Wheeler CH, Yan JX, Weil J, Eschenhagen T, Scholtysik G, et al. Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis 1999;20:898-906.
29. Jiang L, Tsubakihara M, Heinke MY, Yao M, Dunn MJ, Phillips W, et al. Heart failure and apoptosis: electrophoretic methods support data from micro- and macro-arrays. A critical review of genomics and proteomics. Proteomics 2001;1:1481-8.
30. Bogoyevitch MA, Parker PJ, Sugden PH. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res 1993;72:757-67.
31. Gu X, Bishop SP. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res 1994;75:926-31.
32. Koide Y, Tamura K, Suzuki A, Kitamura K, Yokoyama K, Hashimoto T, et al. Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl salt-sensitive rats. Hypertens Res 2003;26:421-6.
33. Braun MU, Szalai P, Strasser RH, Borst MM. Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes. Cardiovasc Res 2003;59:658-67.
34. Roman BB, Goldspink PH, Spaite E, Urboniene D, McKinney R, Geenen DL, et al. Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo. Am J Physiol Heart Circ Physiol 2004;286:H2089-95.
35. Rouet-Benzineb P, Mohammadi K, Perennec J, Poyard M, Bouanani Nel H, Crozatier B. Protein kinase C isoform expression in normal and failing rabbit hearts. Circ Res 1996;79:153-61.
36. Wu G, Toyokawa T, Hahn H, Dorn GW, 2nd. Epsilon protein kinase C in pathological myocardial hypertrophy. Analysis by combined transgenic expression of translocation modifiers and Galphaq. J Biol Chem 2000;275:29927-30.
37. Poortinga G, Hannan KM, Snelling H, et al. MADI and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation. Embo J 2004;23:3325-35.
38. Qoronfleh MW, Ren L, Emery D, Perr M, Kaboord B. Use of Immunomatrix Methods to Improve Protein-Protein Interaction Detection. J Biomed Biotechnol 2003;2003:291-8.